spacer
home > pmps > winter 2002 > improving efficiency and reducing costs - what part do information systems play?
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Improving Efficiency and Reducing Costs - What Part Do Information Systems Play?

The pharmaceutical industry isn't alone in feeling the pressure that companies across almost all markets face to drive down costs, increase profit and grow market share. But these demands are compounded by forces peculiar to pharmaceutical production. These include evolving regulatory requirements, the explosion of competition caused by the dissolution of patent protections and the relationship between drugs and peoples' health. This is a high-cost and high-risk industry. On average it costs $500 million and takes 10 to 12 years to develop a new drug, although only one in three actually yields return on investment (ROI).

Faced with such pressures, it has become imperative for pharmaceutical companies to look at ways to streamline processes and increase efficiency. This starts at the drug development process and runs right through to the manufacture and dispatch of products. Efficiency is crucial to the successful, profitable production of expanding product lines.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Geoff Parker, Commercial Director at Scimcon
Geoff Parker is Commercial Director at scientific information management consultancy Scimcon, where he is responsible for global sales and customer support. Geoff has a particular focus on data management strategy consultancy, and also enjoys a hands-on role advising clients on their information system requirements and system selection.

Before joining Scimcon in June 2000, Geoff spent two years with laboratory information system provider Thermo LabSystems. Prior to working in the lab information systems field, Geoff had a background in chemistry working as a Technical Chemist for a detergent company, after which he spent five years working for a major technology supplier.

spacer
Geoff Parker
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

White Papers

Analysis of Biopharmaceuticals to Conform to ICHQ6B

RSSL

Worldwide, the pharmaceuticals market is anticipated to grow from more than USD 782 billion in 2011 to approach a value of just over USD 971 billion by the end of 2016, registering a CAGR of over 24%. In 2010 the average medicines expenditure per person within the UK was £271, and this is expected to increase with the ageing population. A significant and increasing proportion of these sales are protein-based biotherapeutics or biomolecules. Currently, these account for 19% of the total market, and are growing at twice the rate of traditional small molecule pharmaceuticals. It is predicted that close to 50% of the top 100 pharmaceutical products will be biomolecules by 2016. By far the largest segment of the biopharmaceutical market is the monoclonal antibody (MAb) with an estimated share of 25.6%, which corresponds to USD 51.1 billion.
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement